94 related articles for article (PubMed ID: 8264552)
1. Human m3 muscarinic acetylcholine receptor carboxyl-terminal threonine resides are required for agonist-induced receptor down-regulation.
Yang J; Logsdon CD; Johansen TE; Williams JA
Mol Pharmacol; 1993 Dec; 44(6):1158-64. PubMed ID: 8264552
[TBL] [Abstract][Full Text] [Related]
2. Mutation of carboxyl-terminal threonine residues in human m3 muscarinic acetylcholine receptor modulates the extent of sequestration and desensitization.
Yang J; Williams JA; Yule DI; Logsdon CD
Mol Pharmacol; 1995 Sep; 48(3):477-85. PubMed ID: 7565628
[TBL] [Abstract][Full Text] [Related]
3. Cysteine pairs in the third intracellular loop of the muscarinic m1 acetylcholine receptor play a role in agonist-induced internalization.
Sawyer GW; Ehlert FJ; Shults CA
J Pharmacol Exp Ther; 2008 Jan; 324(1):196-205. PubMed ID: 17540859
[TBL] [Abstract][Full Text] [Related]
4. Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells.
Hu J; Wang SZ; el-Fakahany EE
J Pharmacol Exp Ther; 1991 Jun; 257(3):938-45. PubMed ID: 1710663
[TBL] [Abstract][Full Text] [Related]
5. An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor.
Zhu SZ; Wang SZ; Hu J; el-Fakahany EE
Mol Pharmacol; 1994 Mar; 45(3):517-23. PubMed ID: 8145736
[TBL] [Abstract][Full Text] [Related]
6. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
Lee NH; Geoghagen NS; Cheng E; Cline RT; Fraser CM
Mol Pharmacol; 1996 Jul; 50(1):140-8. PubMed ID: 8700106
[TBL] [Abstract][Full Text] [Related]
7. Role of two highly conserved tyrosine residues in the m1 muscarinic receptor second transmembrane domain in ligand binding and receptor function.
Lee SY; Zhu SZ; el-Fakahany EE
Recept Signal Transduct; 1996; 6(1):43-52. PubMed ID: 8933621
[TBL] [Abstract][Full Text] [Related]
8. Differential modulation of agonist potency and receptor coupling by mutations of Ser388Tyr and Thr389Pro at the junction of transmembrane domain VI and the third extracellular loop of human M(1) muscarinic acetylcholine receptors.
Huang XP; Williams FE; Peseckis SM; Messer WS
Mol Pharmacol; 1999 Oct; 56(4):775-83. PubMed ID: 10496961
[TBL] [Abstract][Full Text] [Related]
9. Site-directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding.
Wess J; Gdula D; Brann MR
EMBO J; 1991 Dec; 10(12):3729-34. PubMed ID: 1657592
[TBL] [Abstract][Full Text] [Related]
10. Double mutant cycle analysis of aspartate 69, 97, and 103 to asparagine mutants in the m2 muscarinic acetylcholine receptor.
Vogel WK; Peterson GL; Broderick DJ; Mosser VA; Schimerlik MI
Arch Biochem Biophys; 1999 Jan; 361(2):283-94. PubMed ID: 9882458
[TBL] [Abstract][Full Text] [Related]
11. Palmitoylation of muscarinic acetylcholine receptor m2 subtypes: reduction in their ability to activate G proteins by mutation of a putative palmitoylation site, cysteine 457, in the carboxyl-terminal tail.
Hayashi MK; Haga T
Arch Biochem Biophys; 1997 Apr; 340(2):376-82. PubMed ID: 9143344
[TBL] [Abstract][Full Text] [Related]
12. On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor.
Christopoulos A; Pierce TL; Sorman JL; El-Fakahany EE
Mol Pharmacol; 1998 Jun; 53(6):1120-30. PubMed ID: 9614217
[TBL] [Abstract][Full Text] [Related]
13. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors.
Maggio R; Vogel Z; Wess J
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):3103-7. PubMed ID: 8385357
[TBL] [Abstract][Full Text] [Related]
14. Regulation of extracellular-signal regulated kinase and c-Jun N-terminal kinase by G-protein-linked muscarinic acetylcholine receptors.
Wylie PG; Challiss RA; Blank JL
Biochem J; 1999 Mar; 338 ( Pt 3)(Pt 3):619-28. PubMed ID: 10051431
[TBL] [Abstract][Full Text] [Related]
15. Beta-Adrenoceptor-medicated down-regulation of M2 muscarinic receptors: role of cyclic adenosine 5'-monophosphate-dependent protein kinase and protein kinase C.
Rousell J; Haddad EB; Mak JC; Webb BL; Giembycz MA; Barnes PJ
Mol Pharmacol; 1996 Apr; 49(4):629-35. PubMed ID: 8609890
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the G-proteins Gq alpha and G11 alpha by transfected human M3 muscarinic acetylcholine receptors in Chinese hamster ovary cells is independent of receptor down-regulation.
van de Westerlo E; Yang J; Logsdon C; Williams JA
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):559-63. PubMed ID: 7654194
[TBL] [Abstract][Full Text] [Related]
17. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA; Doufexis M; Kapas S; Chhajlani V
Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of muscarinic receptor mRNA levels in neuroblastoma cells by chronic agonist exposure: a comparative polymerase chain reaction study.
Steel MC; Buckley NJ
Mol Pharmacol; 1993 May; 43(5):694-701. PubMed ID: 8502226
[TBL] [Abstract][Full Text] [Related]
19. m3 Muscarinic receptor-induced and Gi-mediated heterologous potentiation of phospholipase C stimulation: role of phosphoinositide synthesis.
Schmidt M; Nehls C; Rümenapp U; Jakobs KH
Mol Pharmacol; 1996 Oct; 50(4):1038-46. PubMed ID: 8863852
[TBL] [Abstract][Full Text] [Related]
20. Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor.
Frucht H; Jensen RT; Dexter D; Yang WL; Xiao Y
Clin Cancer Res; 1999 Sep; 5(9):2532-9. PubMed ID: 10499630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
